Trial Profile
The Efficacy of Claritin in Healthy Subjects.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Mar 2018
Price :
$35
*
At a glance
- Drugs Loratadine (Primary)
- Indications Obstructive airway disorders
- Focus Therapeutic Use
- 04 Sep 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 13 Aug 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 19 Jun 2012 Planned end date changed from 1 Sep 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov.